Simplify Logo

Full-Time

Manager/Senior Manager

Quality Assurance

Posted on 7/25/2024

Abata Therapeutics

Abata Therapeutics

11-50 employees

Develops therapies for autoimmune diseases

Hardware
Biotechnology

Senior

Belmont, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s degree or higher in Biology, Chemistry, Microbiology, Life Sciences, or an equivalent scientific discipline
  • Experience in quality or regulatory compliance within pharmaceutical, biologics, or cell therapy manufacturing (cell therapy experience is desired)
  • 5+ years Good Manufacturing Practice (GMP) experience
  • Travel up to 30% (mostly local)
Responsibilities
  • Independently represents Quality Assurance in day-to-day interactions with contract manufacturer and internal cross-functional teams
  • Reviews and approves master batch records, executed batch records, and test procedures and records
  • Dispositions drug product and supports Clinical Trial Material shipment
  • Supports investigations regarding Good Manufacturing Practice (GMP) related quality events
  • Reviews and approves deviations, CAPA, investigations, and out-of-specification investigations
  • Supports change management at contract manufacturer, and maintains/supports internal change management
  • Supports the establishment and oversight of internal translational laboratory and testing
  • Reviews and approves internal protocols and reports
  • Works cross-functionally across the organization
  • Participates in external auditing
  • Supports the establishment of an internal auditing program
  • Administers the QMS system and training program
  • Effectively represents Quality Assurance, both internally and externally

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Abata stands out in the biotech market by targeting a specific niche of autoimmune disease patients and forming strategic partnerships, such as with ElevateBio, to enhance their research and manufacturing capabilities. The company's goal is to transform treatment options for autoimmune diseases through advanced therapies.

Company Stage

Series A

Total Funding

$60.3M

Headquarters

Cambridge, Massachusetts

Founded

2021

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-5%

2 year growth

11%
Simplify Jobs

Simplify's Take

What believers are saying

  • The appointment of industry veterans like Leonard Dragone and Ellen Cahir-McFarland strengthens Abata's leadership team, enhancing its scientific and clinical capabilities.
  • With significant funding, including a recent $95 million equity investment, Abata is well-positioned to accelerate product development and expand its operations.
  • The company's collaborative and enthusiastic work environment, driven by a mission to transform autoimmune disease treatment, offers a fulfilling and impactful career.

What critics are saying

  • The highly specialized focus on Treg cell therapies may limit Abata's market reach and make it vulnerable to advancements by competitors in broader therapeutic areas.
  • Delays in clinical trials or regulatory approvals could hinder the timely commercialization of their lead product, ABA 201, impacting revenue and growth prospects.

What makes Abata Therapeutics unique

  • Abata Therapeutics leverages the unique biology of regulatory T cells (Tregs) to develop transformative therapies for autoimmune diseases, setting it apart from traditional biotech approaches.
  • Their strategic partnership with ElevateBio ensures scalable and regulatory-compliant manufacturing processes, a critical advantage in the competitive biotech landscape.
  • Focused on niche markets like type 1 diabetes and progressive multiple sclerosis, Abata addresses unmet medical needs with innovative Treg cell therapies.
INACTIVE